MedPath

Effectivenessof intranasal vs intravenous dexmedetomidine infusion providing induced hypotension in functional endoscopic sinus surgery(FESS)-A clinical trial

Phase 2
Conditions
Health Condition 1: H60-H95- Diseases of the ear and mastoid process
Registration Number
CTRI/2024/05/067369
Lead Sponsor
DR RAM PANDIAN G
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients belonging to ASA 1 and ASA 2 physical status, surgery duration of less than 3hours

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the Target MAP to achieve bloodless field in the two group of <br/ ><br>patients(IV &IN Dexmedotimine group)Timepoint: At baseline,5mins,10mins,15mins,30mins, <br/ ><br>1hours,1:30hours,2hours,2:30hours,3hours and postoperatively 30min,1hour,1:30hour,2hours
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath